Bovie Medical ROE 2006-2019 | APYX

Current and historical return on equity (ROE) values for Bovie Medical (APYX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Bovie Medical ROE for the three months ending March 31, 2019 was -12.25%.
Bovie Medical ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.06B $0.08B 84.21%
2018-12-31 $0.06B $0.09B 115.32%
2018-09-30 $0.07B $0.09B 171.79%
2018-06-30 $-0.00B $0.02B -13.64%
2018-03-31 $-0.00B $0.02B -17.78%
2017-12-31 $-0.01B $0.02B -21.28%
2017-09-30 $-0.01B $0.02B -20.41%
2017-06-30 $-0.01B $0.02B -20.83%
2017-03-31 $-0.01B $0.03B -21.51%
2016-12-31 $-0.01B $0.03B -22.22%
2016-09-30 $-0.01B $0.02B -22.99%
2016-06-30 $-0.01B $0.02B -26.37%
2016-03-31 $-0.01B $0.02B -25.00%
2015-12-31 $0.01B $0.02B 36.00%
2015-09-30 $0.01B $0.03B 24.39%
2015-06-30 $0.00B $0.03B 23.88%
2015-03-31 $0.01B $0.03B 37.74%
2014-12-31 $-0.02B $0.01B -184.62%
2014-09-30 $-0.02B $0.01B -130.91%
2014-06-30 $-0.02B $0.01B -90.91%
2014-03-31 $-0.02B $0.01B -84.21%
2013-12-31 $-0.01B $0.02B -27.59%
2013-09-30 $-0.00B $0.02B -4.49%
2013-06-30 $-0.00B $0.02B -4.40%
2013-03-31 $0.00B $0.02B 0.00%
2012-12-31 $0.00B $0.02B 0.00%
2012-09-30 $-0.00B $0.02B -4.44%
2012-06-30 $-0.00B $0.02B -4.44%
2012-03-31 $-0.00B $0.02B -4.44%
2011-12-31 $-0.00B $0.02B -4.44%
2011-09-30 $-0.00B $0.02B -4.44%
2011-06-30 $-0.00B $0.02B -4.44%
2011-03-31 $-0.00B $0.02B -4.44%
2010-12-31 $-0.00B $0.02B -4.49%
2010-09-30 $0.00B $0.02B 0.00%
2010-06-30 $0.00B $0.02B 0.00%
2010-03-31 $0.00B $0.02B 0.00%
2009-12-31 $0.00B $0.02B 0.00%
2009-09-30 $0.00B $0.02B 0.00%
2009-06-30 $0.00B $0.02B 0.00%
2009-03-31 $0.00B $0.02B 5.19%
2008-12-31 $0.00B $0.02B 5.33%
2008-09-30 $0.00B $0.02B 16.67%
2008-06-30 $0.00B $0.02B 17.39%
2008-03-31 $0.00B $0.02B 18.18%
2007-12-31 $0.00B $0.02B 25.00%
2007-09-30 $0.00B $0.02B 13.11%
2007-06-30 $0.00B $0.02B 20.69%
2007-03-31 $0.00B $0.02B 22.64%
2006-12-31 $0.00B $0.01B 24.49%
2006-09-30 $0.00B $0.01B 26.67%
2006-06-30 $0.00B $0.01B 19.51%
2006-03-31 $0.00B $0.01B 10.26%
2005-12-31 $0.00B $0.01B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.214B $0.017B
Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.825B 29.16
Medtronic (MDT) Ireland $135.913B 19.41
Stryker (SYK) United States $78.520B 28.02
Boston Scientific (BSX) United States $59.297B 28.43
Baxter (BAX) United States $42.385B 26.71
EssilorLuxottica Societe Anonyme (ESLOY) France $29.267B 0.00
Coloplast (CLPBY) Denmark $25.937B 41.41
Zimmer Biomet Holdings (ZBH) United States $25.411B 16.33
Lonza Group Ag (LZAGY) Switzerland $25.385B 0.00
Terumo (TRUMY) Japan $21.889B 25.17
Smith & Nephew SNATS (SNN) United Kingdom $19.108B 0.00
ResMed (RMD) United States $17.890B 34.18
Canopy Growth (CGC) Canada $12.379B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.239B 48.98
Insulet (PODD) United States $7.299B 531.83
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Hill-Rom Holdings (HRC) United States $7.083B 21.47
Aurora Cannabis (ACB) Canada $7.048B 69.50
Perrigo (PRGO) Ireland $6.991B 11.82
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.299B 51.41
ICU Medical (ICUI) United States $5.103B 30.45
GW Pharmaceuticals (GWPH) United Kingdom $5.007B 0.00
Neogen (NEOG) United States $3.388B 55.09
NuVasive (NUVA) United States $3.018B 24.64
Agios Pharmaceuticals (AGIO) United States $2.894B 0.00
Hutchison China MediTech (HCM) China $2.829B 0.00
National Vision Holdings (EYE) United States $2.507B 53.42
Quidel (QDEL) United States $2.307B 23.94
Aphria (APHA) $1.619B 0.00
Cardiovascular Systems (CSII) United States $1.549B 889.60
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.216B 0.00
VAREX IMAGING (VREX) United States $1.171B 24.86
NanoString Technologies (NSTG) United States $1.107B 0.00
Lantheus Holdings (LNTH) United States $1.086B 28.83
PetIQ (PETQ) United States $1.002B 24.33
Quanterix (QTRX) United States $0.820B 0.00
Cerus (CERS) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.761B 21.35
Omeros (OMER) United States $0.760B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
TG Therapeutics (TGTX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.608B 29.43
Surmodics (SRDX) United States $0.538B 78.24
OraSure Technologies (OSUR) United States $0.525B 24.17
Meridian Bioscience (VIVO) United States $0.492B 15.03
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.465B 0.00
Vapotherm (VAPO) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.324B 22.45
BioLife Solutions (BLFS) United States $0.319B 99.82
Cytosorbents (CTSO) United States $0.246B 0.00
Zynex (ZYXI) United States $0.239B 24.60
Chimerix (CMRX) United States $0.186B 0.00
United Health Products (UEEC) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.167B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.139B 7.32
Female Health (VERU) United States $0.138B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
United-Guardian (UG) United States $0.091B 19.97
InfuSystems Holdings (INFU) United States $0.088B 0.00
Surface Oncology (SURF) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.25
MRI INTERVENTNS (MRIC) United States $0.052B 0.00